DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. Circulation.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

Frontiers in Cardiovascular Medicine

MARCH 28, 2025

Initial causality was assessed by inverse variance weighting (IVW), followed by sensitivity analyses using MR-Egger regression, weighted median, and Multiple Effectiveness Residual Sums and Outliers (MR-PRESSO) method.

Cardiovascular Disease 52

Cardiovascular Disease Atrial Fibrillation Aneurysm Heart Failure 52

American College of Cardiology

FEBRUARY 23, 2024

What is the prevalence of subclinical atrial fibrillation (AF) in patients with heart failure and preserved ejection fraction (HFpEF), and how does it impact outcomes?

Atrial Fibrillation 65

Atrial Fibrillation Preserved Ejection Fraction Heart Failure Outcomes 65

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Cardiomyopathy Heart Failure 64

Frontiers in Cardiovascular Medicine

JANUARY 28, 2024

Introduction A high recurrence rate of atrial fibrillation was monitored after catheter ablation for persistent atrial fibrillation. The primary outcome will be sinus rhythm maintenance rate over 12 months, monitored by random electrocardiogram and 24-h Holter electrocardiogram.

Atrial Fibrillation 64

Atrial Fibrillation Heart Failure Ablation Electrocardiogram 64

American College of Cardiology

FEBRUARY 19, 2025

Atrial fibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heart failure (HF) hospitalization and atrial fibrillation (AFib) recurrence.

AFIB 67

AFIB Ablation Atrial Fibrillation Outcomes 67

Frontiers in Cardiovascular Medicine

JANUARY 28, 2024

Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) have emerged as major age-related epidemics within cardiology. Indeed, these two conditions are commonly found in the same individual, so much so that AF has been used in proposed diagnostic criteria for HFpEF.

Preserved Ejection Fraction 59

Preserved Ejection Fraction Heart Failure Atrial Fibrillation Electrophysiology 59

Frontiers in Cardiovascular Medicine

APRIL 2, 2025

BackgroundThe role of the triglyceride-glucose (TyG) index in critically ill patients with congestive heart failure (CHF) and atrial fibrillation (AF), requiring intensive care unit (ICU) admission, remains unclear. The primary outcome was hospital all-cause mortality.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure ICU Hospital 52

HeartRhythm

MAY 22, 2024

The combined effect of left ventricular ejection fraction (LVEF) and atrial fibrillation (AF) on clinical outcomes in heart failure (HF) remains complex.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Outcomes 40

HeartRhythm

JANUARY 6, 2025

Atrial fibrillation (AF) is a common arrhythmia in patients with heart failure (HF). The coexistence of these conditions can further induce structural changes and result in worsened outcomes such as stroke, HF decompensation, poorly controlled AF, and mortality [1].

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

European Journal of Heart Failure

NOVEMBER 26, 2024

Discontinuation and reinitiation of mineralocorticoid receptor antagonists (MRA) in patients with heart failure and reduced ejection fraction (HFrEF). BMI, body mass index; eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association. 1.38), a diagnosis of atrial fibrillation (HR 1.24, 95% CI 1.10–1.39),

Heart Failure 71

Heart Failure Kidney Disease Atrial Fibrillation BMI 71

Heart BMJ

OCTOBER 10, 2024

The term ‘epidemic’ is increasingly used to describe the rising global prevalence of atrial fibrillation (AF). Indeed, numerous studies are currently investigating the impact of such approaches on clinical outcomes and healthcare utilisation. Recent estimates suggest that AF accounts for between 0.9% 2 Before the.

Atrial Fibrillation 59

Atrial Fibrillation Risk Factors Kidney Disease Heart Failure 59

HeartRhythm

APRIL 30, 2024

The combined effect of Left Ventricular Ejection Fraction (LVEF) and the presence of Atrial Fibrillation (AF) on clinical outcomes in heart failure (HF) patients remains complex.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Outcomes 40

HeartRhythm

AUGUST 18, 2024

The impact of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on atrial fibrillation (AF) recurrence outcomes and adverse cardiovascular outcomes in heart failure (HF) patients after AF ablation is unknown.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

Open Heart

AUGUST 10, 2023

Background Atrial fibrillation (AF) is common in individuals with heart failure (HF). A statistically significant improvements in exercise capacity, heart disease QoL, anxiety and depression scores were observed within each group. Evidence supported the effect of exercise training in individuals with HF.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Atrial Fibrillation Heart Failure Quality of Life 52

HeartRhythm

OCTOBER 21, 2024

Clinical outcomes among patients with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) treated with catheter ablation (CA) versus antiarrhythmic therapy (AAT) are not well-known.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

Journal of Cardiovascular Electrophysiology

AUGUST 7, 2023

Abstract A vast amount of now well-established clinical and epidemiological data indicates a close, interdependent, and symbiotic association between atrial fibrillation (AF) and heart failure (HF). Both AF and HF, when co-exist in a patient, have serious treatment and prognostic implications.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

European Journal of Heart Failure

FEBRUARY 5, 2025

Methods and results TRED-HF was a randomized trial investigating heart failure therapy withdrawal in patients with recovered DCM over 6months. Clinical outcomes are reported in a non-randomized fashion from enrolment and from the end of the trial.

Heart Failure 67

Heart Failure Cardiomyopathy Atrial Fibrillation Arrhythmia 67

HeartRhythm

MAY 2, 2024

The authors claim that their score identifies heart failure (HF) patients who benefit the most from atrial fibrillation (AF) ablation. More than identifying patients who benefit from the ablation, the score seems to identify patients who will have worse outcomes, irrespective of the treatment strategy.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

HeartRhythm

APRIL 30, 2024

Leukocyte telomere length (LTL) is a well-established biomarker linked to cardiovascular disease, with shorter LTL associated with increased severity of heart failure (HF) outcomes. It is also well known that atrial fibrillation (AF) and HF are closely related and often coexist.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Biomarkers Cardiovascular Disease 40

HeartRhythm

APRIL 30, 2024

Studies have suggested that early atrial fibrillation (AF) ablation is associated with improved outcomes. However, it is unknown whether these patterns hold for persistent AF among patients with heart failure with preserved ejection fraction (HFpEF). The majority of these studies evaluated paroxysmal AF cases.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

APRIL 30, 2024

Catheter ablation (CA) for atrial fibrillation (AF) and heart failure with reduced ejection fraction <40% (HFrEF) is associated with improved outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Quality of Life 40

European Journal of Heart Failure

FEBRUARY 25, 2025

Overview of the study population and effects observed after catheter ablation for atrial fibrillation. Conclusion Atrial fibrillation ablation in end-stage HF leads to a substantial decrease in AF burden, a regression from persistent to paroxysmal AF and notably improved LVEF. PVI, pulmonary vein isolation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Arrhythmia 40

HeartRhythm

APRIL 30, 2024

A number of studies have examined the impact of atrial fibrillation (AF) ablation on outcomes in heart failure (HF) with reduced ejection (HFrEF) patients. In contrast, data from HF with preserved ejection fraction (HFpEF) patients is limited to small outcome studies and less robust meta-analyses.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Ablation Outcomes 40

HeartRhythm

APRIL 30, 2024

Previous studies have demonstrated significant morbidity and mortality in patients with heart failure (HF) with reduced ejection fraction (HFrEF), particularly with accompanying atrial fibrillation (AF).

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) with comorbid heart failure with preserved ejection fraction (HFpEF) presents a significant management challenge. While the association between AF and heart failure with reduced ejection fraction is extensively studied, the correlation between AF and HFpEF remains less explored.

Atrial Fibrillation 40

Atrial Fibrillation Preserved Ejection Fraction Heart Failure Hospital 40

Journal of Cardiovascular Electrophysiology

MARCH 3, 2025

ABSTRACT Background Atrial fibrillation (AF) recurrence remains a significant challenge in heart failure with reduced ejection fraction (HFrEF) patients undergoing cryoballoon ablation (CBA). This study assesses the impact of SGLT2i on AF recurrence and clinical outcomes in HFrEF patients undergoing CBA.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

HeartRhythm

JANUARY 23, 2025

The prevalence of atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM) is reported to be higher than in the general population, ranging from 3.6% to 8.9 % [1].

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Outcomes Cardiovascular Disease 40

HeartRhythm

APRIL 30, 2024

Right ventricular (RV) function is an important predictor of outcomes in patients with heart failure. The prevalence of RV dysfunction in patients with atrial fibrillation (AF) remains unclear.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Outcomes 40

HeartRhythm

APRIL 30, 2024

Catheter ablation (CA) of atrial fibrillation (AF) has been proved to benefit patient with symptomatic AF and heart failure. However, the data on neurological outcomes including cerebrovascular disease (CVA) and dementia remain a controversy.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Cerebrovascular Disease Dementia 40

HeartRhythm

APRIL 30, 2024

Overtime, various studies have reported variable mortality outcomes in heart failure with preserved ejection fraction (HFpEF) patients. It remains unclear to what extent atrial fibrillation (AF) creates increased mortality alone or in combination with either HFpEF or heart failure with reduced ejection fraction (HFrEF).

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Outcomes 40

HeartRhythm

APRIL 30, 2024

The earlier indication of catheter ablation (CA) to atrial fibrillation (AF) had suggested the better outcome post-CA before advancement in left atrial remodeling. However, the optimal timing of CA in patients with a low burden of AF remains unknown.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Document Outcomes 40

HeartRhythm

APRIL 30, 2024

Catheter ablation (CA) has become a cornerstone in the management of patients with comorbid atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF). Multiple trials have demonstrated the efficacy of CA with respect to symptom improvement and quality of life in AF patients with HFrEF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Quality of Life Heart Failure 40

HeartRhythm

APRIL 30, 2024

Catheter ablation(CA) is a class 1 indication in patients with atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF). It is unclear whether complications differ in patients with HFrEF vs normal left ventricular ejection fraction(LVEF).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Outcomes 40

AMS Cardiology

DECEMBER 14, 2023

Atrial fibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. In some cases, AFib can also increase the risk of stroke, blood clots and heart failure. The post How to Prevent an Atrial Fibrillation Attack appeared first on AMS Cardiology.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Blood Clot Heart Rhythm 52

Dr. Smith's ECG Blog

APRIL 2, 2024

So it must be atrial fibrillation. Answer : it is irregularly irregular and the initial part of the QRS is fast, so this is atrial fibrillation with Left Bundle Branch Block (LBBB). It stated that he had a non-ischemic cardiomyopathy, with EF of 15% and atrial fibrillation, and a normal angiogram 3 years prior.

Tachycardia 131

Tachycardia Pacemaker Cardiac Arrest Cardiomyopathy 131

HeartRhythm

SEPTEMBER 25, 2024

The HFA–PEFF score comprising echocardiographic and laboratory data is designed to diagnose heart failure with preserved ejection fraction and holds prognostic value in patients who underwent catheter ablation for atrial fibrillation (AF).

Preserved Ejection Fraction 40

Preserved Ejection Fraction Laboratory Atrial Fibrillation Ablation 40